Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KORU Medical Systems, Inc. - Common Stock (NQ:KRMD)

3.400 -0.730 (-17.68%)
Streaming Delayed Price Updated: 9:51 AM EDT, Aug 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about KORU Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
Kaskela Law LLC Announces Investigation of KORU Medical Systems, Inc. (KRMD) and Encourages Long-Term KRMD Shareholders to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces First Quarter 2026 Results
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
From KORU Medical Systems Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces CEO Transition
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
Via ACCESS Newswire
News headline image
ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
From ForCast Orthopedics, Inc.
Via Business Wire
News headline image
Cirtec Medical Announces Appointment of New Chief Executive Officer
From Cirtec Medical
Via GlobeNewswire
News headline image
KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference
From KORU Medical Systems, Inc
Via Business Wire
News headline image
KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes
From KORU Medical Systems, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.